Cambridge Investment Research Advisors, Inc. Acurx Pharmaceuticals, Inc. Put Options Transaction History
Cambridge Investment Research Advisors, Inc.
- $32.9 Billion
- Q2 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding ACXP
# of Institutions
32Shares Held
2.57MCall Options Held
62.9KPut Options Held
56.9K-
Armistice Capital, LLC New York, NY1.08MShares$5.1 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA146KShares$692,4900.0% of portfolio
-
Morgan Stanley New York, NY106KShares$502,3300.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny87.8KShares$415,2040.0% of portfolio
-
Sabby Management, LLC Upper Saddle River, NJ81.9KShares$387,3491.04% of portfolio
About Acurx Pharmaceuticals, Inc.
- Ticker ACXP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 11,556,600
- Market Cap $54.7M
- Description
- Acurx Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops antibiotics to treat bacterial infections. Its lead antibiotic candidate is ibezapolstat, a novel mechanism of action that targets the polymerase IIIC enzyme that has completed Phase II clinical trial to treat patients with clostridium difficile infections. The com...